A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations
- 11 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal Of Impotence Research
- Vol. 18 (6), 559-565
- https://doi.org/10.1038/sj.ijir.3901479
Abstract
Several trials and reviews provide evidence for the efficacy of phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction (ED). However, little is known about the impact of treatment effect modifiers other than concomitant diseases. Our objective was to identify patient and trial characteristics as well as methodological and publication-related issues that are associated with the treatment effect measured in flexible-dose randomized controlled trials of oral sildenafil for ED. The MEDLINE and the Cochrane Central databases were searched for efficacy trials of sildenafil. Thirteen trials fulfilled all inclusion criteria. A series of meta-regression and graphical analyses were performed to test the impact of possible effect modifiers. Treatment effect was influenced by mean baseline disease severity and mean duration of the disease. These associations were at least partly mediated by placebo response. Trial duration, age of patients and etiology of ED in patients did not have any significant influence on the treatment effect. The year of publication of primary trials was also related to trial findings. Our analysis adds important data to enable the control of confounding variables in future trials and meta-analyses. It might also help the individual to assess the unbiased efficacy and true innovative potential of available and forthcoming pharmacological agents.Keywords
This publication has 40 references indexed in Scilit:
- Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunctionBJU International, 2005
- Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reportsInternational Journal Of Impotence Research, 2004
- Controlling the risk of spurious findings from meta‐regressionStatistics in Medicine, 2004
- Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population studyInternational Journal Of Impotence Research, 2003
- Efficacy and safety of sildenafil citrate (Viagra®) for the treatment of erectile dysfunction in men in Egypt and South AfricaInternational Journal Of Impotence Research, 2003
- Epidemiology of erectile dysfunctionInternational Journal Of Impotence Research, 2003
- Sildenafil citrate (Viagra®) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation studyInternational Journal Of Impotence Research, 2002
- Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly headStatistics in Medicine, 2002
- EFFICACY, SAFETY AND PATIENT ACCEPTANCE OF SILDENAFIL CITRATE AS TREATMENT FOR ERECTILE DYSFUNCTIONJournal of Urology, 2000
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996